Clinical trial
Development of a Therapeutic Endpoint in Pediatric IBD Conditions
NCT06065228 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Therapeutic Endpoint in Pediatric IBD Conditions
- Lead sponsor
- Children's National Research Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 27, 2023
- Completion date
- December 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.